KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Common Equity (2020 - 2026)

Organon has reported Common Equity over the past 7 years, most recently at $903.0 million for Q1 2026.

  • For Q1 2026, Common Equity rose 66.61% year-over-year to $903.0 million; the TTM value through Mar 2026 reached $903.0 million, up 66.61%, while the annual FY2025 figure was $752.0 million, 59.32% up from the prior year.
  • Common Equity for Q1 2026 was $903.0 million at Organon, up from $752.0 million in the prior quarter.
  • Over five years, Common Equity peaked at $906.0 million in Q3 2025 and troughed at -$1.2 billion in Q1 2022.
  • A 5-year average of -$76.6 million and a median of $48.0 million in 2024 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: plummeted 126.47% in 2022 and later soared 1029.17% in 2025.
  • Year by year, Common Equity stood at -$892.0 million in 2022, then surged by 92.15% to -$70.0 million in 2023, then surged by 774.29% to $472.0 million in 2024, then soared by 59.32% to $752.0 million in 2025, then increased by 20.08% to $903.0 million in 2026.
  • Business Quant data shows Common Equity for OGN at $903.0 million in Q1 2026, $752.0 million in Q4 2025, and $906.0 million in Q3 2025.